EPTAM Precision | AI Transformation Index
EPTAM Precision is a structurally durable physical manufacturer whose moats — regulatory certification, customer validation requirements, capital equipment...

Overview
EPTAM Precision is a contract manufacturer specializing in precision CNC machining, micro-machining, laser cutting/welding, and plastic injection molding of components for medical device and life science OEMs, generating revenue on a fee-for-service basis.
Executive Summary
EPTAM Precision is a structurally durable physical manufacturer whose moats — regulatory certification, customer validation requirements, capital equipment intensity, and multi-decade supplier relationships — are almost entirely immune to AI substitution. The AI opportunity is real but modest: machine monitoring, scheduling optimization, and vision-based quality inspection can improve margins and throughput at the edges, and EPTAM has already demonstrated willingness to adopt such tools. The strategic implication for a PE investor is that this is a durability story, not an AI transformation story — protect and extend the manufacturing capability moat, use AI as an operational efficiency lever, and don't expect AI to be the primary value-creation driver.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
52.9
Ciridae AI Score
Durability Rationale
EPTAM is structurally well-insulated from AI disruption because its core product is a physical, precision-fabricated component, not an information or cognitive output. The barriers protecting this business — FDA quality system requirements, customer validation cycles, heavy capital equipment, and multi-year supplier qualifications — are precisely the kind of moats that become relatively stronger as AI commoditizes cognitive work. No amount of AI capability allows an entrant to bypass the need for certified cleanrooms, CNC machining centers, and validated manufacturing processes. The fragmented CMO market and moderate pricing power are the primary durability risks, but these are competitive dynamics predating AI, not AI-driven vulnerabilities.
Opportunity Rationale
AI is a modest deal for EPTAM — relevant at the operational periphery but structurally limited by the physical nature of the production function. The highest-value AI applications are operational: machine monitoring and utilization analytics (already being captured via Datanomix), production scheduling optimization, computer vision for quality inspection, and predictive maintenance. These can drive meaningful efficiency gains and were already demonstrated to contribute to revenue growth. But AI cannot compress the core value-creating activity — running precision machinery to fabricate physical components — so the unrealized step-change is bounded. This is an efficiency story, not a transformation story.
Key Risks
If AI-enabled generative design and simulation tools allow OEMs to dramatically simplify component geometries — reducing the precision and customization required — EPTAM's specialized manufacturing premium could erode as more standard CMOs become qualified substitutes.
If computer vision and AI-driven process control advance to the point where fully automated precision manufacturing becomes viable with minimal skilled labor, the barrier to new physical entrants (offshore or domestic) could compress faster than anticipated, limiting the operational efficiency upside while simultaneously threatening market position.
Company Overview
| Headquarters | Northfield, New Hampshire, United States |
| Products / Services | Precision machining of polymers and metals, Micro-machining, Laser cutting and welding, Plastic injection molding |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
EPTAM Precision acquired Sterling Manufacturing Announced October 28, 2022 | The acquisition expanded EPTAM's capabilities in plastic injection molding and liquid silicone rubber molding, strengthening its position in medical device and other markets. |
Acquired by Frazier Healthcare Partners December 2019 | Frazier Healthcare Partners acquired EPTAM Precision Solutions, a diversified outsourced manufacturer of medical device and high precision components. |
Executives
| Name | Background |
|---|---|
Mark Kemp Chief Executive Officer (CEO) | Over 30 years of leadership experience in business development, mergers & acquisitions, operations, supply chain, and R&D. Expertise in the medical device manufacturing industry. |
Graham Schillmoller Chief Financial Officer (CFO) | Financial leadership experience across pharmaceutical and healthcare technology sectors. Previously advanced from Controller to CFO, guiding acquisitions and financial transformations. |
Steve Cardin Chief Operations Officer (COO) | Over 25 years of global operations leadership in medical device contract manufacturing. Previous roles include VP & COO at UFP Technologies. |
Bill Flaherty President & Chief Commercial Officer (CCO) | Extensive MedTech experience from leadership roles in private equity and contract manufacturing. |
Emmanuel (Manny) Nyakako Vice President, Quality and Regulatory Affairs | Over 25 years of global management experience in quality, regulatory, and operational excellence. |
Kerry Dubois Vice President, Human Resources | Over 20 years at EPTAM, shaping company culture. Leads training, strategic communication, and growth initiatives. |
Frazier Healthcare Partners